Home NDC 0143-9857-01 NDC 0143-9857-01 - Ceftriaxone This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0143-9857
Requested NDC 0143-9857-01
Package NDCs from labels 0143-9857-01, 0143-9857-25
Manufacturer Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
Effective date 2026-09-30
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0143-9857-01 Ceftriaxone 1 in 1 VIAL INJECTION, POWDER, FOR SOLUTION 1 17 0143-9857-25 Ceftriaxone 25 in 1 BOX INJECTION, POWDER, FOR SOLUTION 25 17
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0143-9857 CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] 16 Current NDC, Legacy NDC, 2 package rows 20230312_8351aa37-552d-471d-b293-c564dcb6ec29.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEFTRIAXONE SODIUM ACTIVE INGREDIENT 023Z5BR09K CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICALS CORP] 12 CEFTRIAXONE ACTIVE MOIETY 75J73V1629 CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICALS CORP] 12
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 37 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP 790279d4-2456-4091-abec-960b78885432 2024-02-01 Warnings, Adverse reactions Exact identifier rxcui: 1665005 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM A-S Medication Solutions 1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c 2024-01-31 Warnings, Adverse reactions Exact identifier rxcui: 309092 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM A-S Medication Solutions ff8e830a-c288-46fb-9e19-ec2017943c07 2024-01-31 Warnings, Adverse reactions Exact identifier rxcui: 309092 unii: 023Z5BR09K ceftriaxone CEFTRIAXONE Sagent Pharmaceuticals 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 2023-11-08 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Fresenius Kabi USA, LLC 7ea1db43-40fa-417b-8911-ae98092070a0 2023-09-30 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Asclemed USA, Inc. f01cf0e5-caaf-4759-ba21-50f3aceff523 2023-09-02 Warnings, Adverse reactions Exact identifier rxcui: 1665005 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Apotex Corp. 5116231f-82d1-44be-b08e-560c9a50e5c5 2023-08-31 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Apotex Corp. ac03a72c-0e35-40f9-b7fc-081badb5f19c 2023-01-28 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE SODIUM Samson Medical Technologies, LLC 5cd2d96f-83e5-4326-ae87-d0ede4ba493a 2023-01-15 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Proficient Rx LP fcf401df-bcdc-4773-a63b-9741c0f74b3d 2022-11-01 Warnings, Adverse reactions Exact identifier rxcui: 1665046 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 2022-10-01 Warnings, Adverse reactions Exact identifier rxcui: 1665046 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP 42ba7a9d-7d2b-4eac-af59-897151a8c924 2022-05-02 Warnings, Adverse reactions Exact identifier rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Hospira, Inc 9d1f630b-e759-4395-9d01-ddc90e4fea75 2022-03-09 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K CEFTRIAXONE AND DEXTROSE CEFTRIAXONE B. Braun Medical Inc. 67153914-16bc-490d-82d7-638061618467 2022-01-13 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K 22f5b167-43fa-4fdf-9687-506a02e372e5 8351aa37-552d-471d-b293-c564dcb6ec29 2021-12-01 Warnings, Adverse reactions Exact identifier spl id: 22f5b167-43fa-4fdf-9687-506a02e372e5 spl set id: 8351aa37-552d-471d-b293-c564dcb6ec29 a29859d7-7168-93a9-e053-2995a90aa638 c46cdb31-4293-4f61-854e-70773096c14b 2020-04-06 Warnings, Adverse reactions Exact identifier spl id: a29859d7-7168-93a9-e053-2995a90aa638 spl set id: c46cdb31-4293-4f61-854e-70773096c14b Ceftriaxone CEFTRIAXONE Hikma Pharmaceuticals USA Inc. 1f8776bd-4f5b-427a-849a-6b8338f7997d 2019-04-24 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.